Bagneux (France) – Genomic Vision (FR0011799907 – GV, the “Company”), a biotechnology company listed on Euronext developing products and services for the precise characterization of DNA sequences, announces that it has today made a declaration of cessation of payments to the Nanterre Commercial Court.
If you wish to receive all of the company’s financial communications in real time, you can register directly by email to the following address: [email protected]